Europe
Promore Pharma AB held Extraordinary Shareholder’s Meeting on Tuesday, 22 October 2019.
Centrient Pharmaceuticals (“Centrient”), the global leader in the production and commercialisation of sustainable, enzymatic antibiotics, next generation statins and anti-fungals, announced that it has
Researchers at UCL Queen Square Institute of Neurology and the UCLH National Hospital for Neurology & Neurosurgery are set to test whether a drug can slow progression of the devastating neurodegenerative condition Multiple System Atrophy
The theme of the 2019 World Congress of Neurology (WCN 2019), Accelerating the Pace of Change, emphasizes the global effort to further neurological healthcare, and serves as a springboard to advance the field of neurology around the globe.
APEIRON Biologics AG announced that it will present preclinical data for its clinical stage project APN401 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, 26-30 October 2019 in Boston, MA, USA.
Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry, has announced the launch of its new Sartocheck® 5 Plus filter integrity tester.
Companies have raised over 6x more investment thanks to grant funding
Achilles Therapeutics, a biopharmaceutical company developing personalised cancer immunotherapies, announces it has appointed Beverley Carr as Chief Business Officer, with effect from 4 November 2019.
New solution supports injection of different viscosities and volumes without the need for system customization
Santhera Pharmaceuticals announces that the UK’s Medicines and Healthcare Products Regulatory Agency has informed ReveraGen BioPharma about having designated vamorolone as Promising Innovative Medicine for the treatment of Duchenne muscular dystrophy
PRESS RELEASES